Headline
The latest stories from AHA Today.
The House Energy and Commerce Committee today voted 51-0 to approve an amended version of the 21st Century Cures Act (H.R. 6). Reductions to payments for hospital services were not included as an offset in the final package. In addition, the bill does not include changes to the 340B Drug…
The Centers for Medicare & Medicaid Services today issued a final rule on oversight of CMS-approved accreditation programs. The final rule amends the regulations for how national Accrediting Organizations apply for and maintain accreditation programs through which health care providers may…
Notices of intent to apply to participate in the Medicare Shared Savings Program beginning Jan. 1 are due May 29. Eligible hospitals and other care providers and suppliers may participate in the program by creating or participating in an accountable care organization. CMS will review the MSSP…
It’s time for regulators to recognize the changing health care landscape and remove obstacles on the road to collaboration, according to an AHA advertorial published today in the Wall Street Journal. “Our health care system is like a hybrid engine sitting on a vintage chassis,…
A cyber attack against a database at health insurer CareFirst BlueCross BlueShield serves as another potent reminder to hospitals and other health care organizations of the importance of ongoing initiatives to prevent and protect against cybersecurity risks.
The House Energy and Commerce Committee today voted 51-0 to approve H.R. 6, the 21st Century Cures Act. The cost of the $13 billion legislation is not offset by cuts in payments for hospital services – a concern that was expressed this week by the AHA in letters to the committee.
The AHA today urged the House Energy and Commerce Committee not to cut payments to hospitals to pay for Section 2123 of the 21st Century Cures Act, which provides for additional payment under Medicare Part A with respect to patient discharges involving new antimicrobial drugs.
The Senate Special Committee on Aging today held a hearing to examine “solutions to the hospital observation stay crisis.” Testifying for the AHA, Jyotirmaya Nanda, M.D., system medical director for informatics and physician compliance at the Center for Clinical Excellence and…
The AHA today urged the Food and Drug Administration to revise its draft guidance for mixing, diluting or repackaging biological products to permit longer beyond-use-dates if testing or validated studies show increased sterility and stability in a similar environment. “The AHA is concerned…